Nieuwsbrief

Deze e-learning wordt aangeboden in samenwerking met de University of Arizona. De e-learning is al jaren in de VS geaccrediteerd voor 7.25 AMA (Amerikaanse accreditatie) voor alle artsen. De kwaliteit is hoogstaand en er wordt gewerkt met verschillende werkvormen (interactieve casuistiek, quizen en video). De geschatte tijdsinvestering is 7.25 uur. Alle onderdelen zijn engels, zo ook de toelichting hieronder.

Build on your integrative knowledge, in this course focused on addressing patients with depression. According to the Centers for Disease Control (CDC), in 2020, one in five adults in the US reported a diagnosis of depression by their health provider. Depression is a major contributor to morbidity, mortality, and economic cost. It cuts across socioeconomic boundaries, race, age, and gender and is associated with serious comorbidities such as cardiovascular disease, obesity, chronic pain, diabetes, and substance abuse.

Within conventional practice, the combined use of antidepressant medications and psychotherapy has been considered the standard recommendation for the treatment of all patients with major depressive disorder (MDD). Increasingly, however, the reliance on medications has been questioned in the scientific literature.